Back to search

University of Glasgow

Understanding recurrent vulvovaginal candidiasis as a dynamic biofilm disease of Candida and Lactobacillus

Abstract

dc:description.abstract

Additionally, women with RVVC using hormonal contraceptives were found to have a more similar bacterial profile to healthy women, compared with women using other contraceptives. C. albicans biofilm reduction by Lactobacillus species was observed in an in vitro co-culture model. Further, RNA sequencing revealed an α-amino acid biosynthesis/breakdown pathway by which L. crispatus may out-compete C. albicans during VVC to re-establish vaginal health. Finally, bi-daily addition of L. crispatus was shown to reduce C. albicans composition within a complex biofilm model. This study highlights the potential impact of Candida biofilm formation in RVVC and the importance of the consideration of biofilms for diagnosis and treatment. Additionally, it contributes to our current understanding of the vaginal microbiome during RVVC and antagonistic interactions between Candida and Lactobacillus. This work provides a foundation for future studies to further elucidate triggers for the development and recurrence of VVC/RVVC and the pathogenesis of the microbes involved. This and similar work will hopefully lead to the development of novel, more appropriate prevention and treatment options for persistent, azole resistant VVC. Additionally, women with RVVC using hormonal contraceptives were found to have a more similar bacterial profile to healthy women, compared with women using other contraceptives. C. albicans biofilm reduction by Lactobacillus species was observed in an in vitro co-culture model. Further, RNA sequencing revealed an α-amino acid biosynthesis/breakdown pathway by which L. crispatus may out-compete C. albicans during VVC to re-establish vaginal health. Finally, bi-daily addition of L. crispatus was shown to reduce C. albicans composition within a complex biofilm model. This study highlights the potential impact of Candida biofilm formation in RVVC and the importance of the consideration of biofilms for diagnosis and treatment. Additionally, it contributes to our current understanding of the vaginal microbiome during RVVC and antagonistic interactions between Candida and Lactobacillus. This work provides a foundation for future studies to further elucidate triggers for the development and recurrence of VVC/RVVC and the pathogenesis of the microbes involved. This and similar work will hopefully lead to the development of novel, more appropriate prevention and treatment options for persistent, azole resistant VVC.

Degree

thesis:*
Level dc:type.qualificationlevel
PhD
Grantor dc:publisher.institution
University of Glasgow
Year dc:date.issued
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • McKloud, Emily

Subjects

dc:subject × 2

Rights

Language dc:language
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Glasgow
Base URL
theses.gla.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

McKloud, Emily. Understanding recurrent vulvovaginal candidiasis as a dynamic biofilm disease of Candida and Lactobacillus. PhD thesis, University of Glasgow, 2021. https://doi.org/10.5525/gla.thesis.82609